10 results match your criteria: "and IRCCS Ca' Granda - Maggiore Policlinico Hospital Foundation[Affiliation]"

Myeloid Sarcoma (MS) is a rare malignancy that can present as an isolated disease or more frequently in association with or following acute myeloid leukemia or other myeloid neoplasms and rarely following myelofibrosis. Since molecular pathogenesis and prognostic factors of MS are not well understood, its prognosis remains poor even in the era of novel agents and target therapies. We report the case of a patient with MS following myelofibrosis with multiple subcutaneous, cutaneous and muscle localizations; the latter has been reported in the literature as anecdotal.

View Article and Find Full Text PDF

Unlabelled: Morbidity and mortality of BCR-ABL1-negative myeloproliferative neoplasm (MPN) patients are influenced by disease-related hemostatic complications, mostly of thrombotic nature. The pathogenesis of thrombosis is multifactorial: in particular, it has been demonstrated that a deregulated expression of Mac1 (also known as surface receptor integrin CD18/CD11b) by leukocytes has a role in favoring platelets' activation in MPN patients. Based on these data, we investigated the epigenetic status of CD18/CD11b in 78 primary myelofibrosis (PMF) patients to explore any possible association between the epigenetic profiles of these two genes and thrombotic risk.

View Article and Find Full Text PDF

The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations.

Mod Pathol

February 2017

Oncohematology Division, IRCCS Ca' Granda-Maggiore Policlinico Hospital Foundation, and Department of Oncology and Oncohematology, University of Milan, Milan, Italy.

Article Synopsis
  • The study analyzes 71 patients with unclassifiable myeloproliferative neoplasms, noting that most exhibit hypercellular bone marrow and various features like increased granulopoiesis and megakaryocytes.
  • About 59% of cases show severe bone marrow fibrosis, while lab results indicate normal hemoglobin and white blood cell counts but increased platelets and lactate dehydrogenase levels.
  • The study identifies distinct morphological clusters among cases, revealing that this category is heterogeneous, suggesting the need for subgroup identification to improve patient management.
View Article and Find Full Text PDF

Erdheim-Chester Disease With Multiorgan Involvement, Following Polycythemia Vera: A Case Report.

Medicine (Baltimore)

May 2016

From the Oncohematology Division, IRCCS Ca' Granda - Maggiore Policlinico Hospital Foundation, and University of Milan (AI, DC, NO, PB, AC); Oncohematology Unit of the Elderly, IRCCS Ca' Granda - Maggiore Policlinico Hospital Foundation (AI); Unit of Medicine and Clinical Immunology, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University (LD, GC); Unit of Pathology, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University (CD); and Hematopathology Service, Division of Pathology, Department of Pathophysiology and Transplantation, University of Milan and IRCCS Ca' Granda - Maggiore Policlinico Hospital Foundation, Milan, Italy (UG).

Erdheim-Chester disease is a rare form of non-Langerhans cell histiocytosis characterized by the migration and infiltration of lipid-laden CD68, CD1a and S100 histiocytes to various target organs, which leads to the disruption of physiological tissue architecture and reactive fibrosis, and thus impairs organ function.We describe the first case of a patient with Erdheim-Chester disease with multiorgan involvement developed after 6 years from polycythemia vera diagnosis. During the follow-up, an abdominal ultrasound scan revealed the presence of dense, bilateral perinephric infiltration.

View Article and Find Full Text PDF

We examined a consecutive series of 29 patients with myeloproliferative neoplasms (MPNs) associated with splanchnic vein thrombosis (SVT) in order to evaluate their bone marrow morphology and identify possible associations between histological findings and clinical features. Eleven patients showed the morphological features of polycythemia vera (PV), 11 of primary myelofibrosis (PMF) and six of essential thrombocythemia (ET). Molecular analyses identified the JAK2 V617F mutation in 27 patients; one of the JAK2-negative patients carried the MPL W515K mutation, the other was "triple-negative" (no JAK2, MPL or CALR mutation).

View Article and Find Full Text PDF

Background: Shortened leukocyte telomere length (LTL) is a marker of cardiovascular risk that has been recently associated with long-term exposure to ambient particulate matter (PM). However, LTL is increased during acute inflammation and allows for rapid proliferation of inflammatory cells. Whether short-term exposure to proinflammatory exposures such as PM increases LTL has never been evaluated.

View Article and Find Full Text PDF